Helminthiasis clinical trials
The registry lists 37 studies for Helminthiasis across more than 10 countries. 2 are recruiting or about to start. 18 of them are mainly about Helminthiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its 13 narrower conditions too, such as Schistosomiasis: 321 studies, 42 open.
Get an email when these change. Save the Helminthiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (3) · University of Washington (3) · London School of Hygiene and Tropical Medicine (2) · Drugs for Neglected Diseases (2) · Universidad Nacional de Salta (2) · Jennifer Keiser (2) · DBL -Institute for Health Research and Development (2) · Boston Medical Center (1)
What is being tested here
Drugs under test in Helminthiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Albendazole | 0 | 2 | 13 |
| Ivermectin | 0 | 1 | 3 |
| Emodepside | 0 | 0 | 2 |
| Praziquantel | 0 | 0 | 2 |
| Moxidectin | 0 | 1 | 1 |
| Triiodothyronine | 0 | 0 | 1 |
| Mebendazole | 0 | 0 | 1 |
| Ferrous sulfate | 0 | 0 | 1 |
| Oxfendazole | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
Who these studies take
Of the 2 Helminthiasis studies recruiting now, 0 (0%) set no upper age limit and 1 (50%) stop at 75 or younger. 2 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (100%) | 2 (100%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 37 studies, recruiting or not: 73% stop at 75 or younger and 68% at 65; 68% take children; 0% are for women only and 8% for men only; 51% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 37 of 37. search them.
- Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT000014061 country
- Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)RecruitingNCT06128447Phase 31 country
- Host Response to Infection and Treatment in Filarial DiseasesActive, not recruitingNCT000012301 country
- Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)CompletedNCT03014167Phase 33 countries
- Tuberculosis - Learning the Effect of Parasites and Reinforcing DietsCompletedNCT050484852 countries
- Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal WormsTerminatedNCT05124691Phase 2/33 countries
- Co-administration of IVM and ALB in School-based Deworming in UgandaCompletedNCT064970751 country
- Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administrationCompletedNCT04700423Phase 2/31 country
- Emodepside Phase II Trial for Treatment of OnchocerciasisActive, not recruitingNCT05180461Phase 22 countries
- Assessment of Drug Efficacy of Local AlbendazoleCompletedNCT02420574Not applicable
- Urine Albendazole Levels for Coverage AssessmentCompletedNCT04041427Not applicable1 country
- Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric PatientsCompletedNCT04041453Phase 22 countries
- First in Man Clinical Trial of Emodepside (BAY 44-4400)CompletedNCT02661178Phase 11 country
- The Longevity of Trichuris Trichiura ColonizationCompletedNCT04227925
- Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene EducationStatus unknownNCT04227834Not applicable1 country
- Comparison of Immune Response in Normal Volunteers and Patients With Helminth InfectionsCompletedNCT000049961 country
- Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in AdultsWithdrawnNCT02636803Phase 2
- The Effect of an Urban Sanitation Intervention on Child HealthCompletedNCT02362932Not applicable1 country
- Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in KenyaCompletedNCT02397772Phase 41 country
- Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)CompletedNCT03173742Phase 1
- Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child HealthCompletedNCT02396407Not applicable1 country
- Design and Clinical Evaluation of a School Meal With Deworming PropertiesCompletedNCT02725255Phase 2/3
- Effect of Hookworm Elimination and Vitamin A Intervention on Iron Status of Preschool Children in Sichuan, ChinaCompletedNCT02675140Phase 4
- Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationCompletedNCT02385058Phase 41 country
- Taenia Solium Control Case Study in ZambiaCompletedNCT01368354Not applicable1 country
- Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionCompletedNCT00507221Not applicable1 country
- Bioequivalence Study of Albendazole 400 mg Tablets in Chinese PopulationCompletedNCT01755637Phase 11 country
- Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut MicrofloraCompletedNCT01192802Phase 41 country
- An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for HelminthsTerminatedNCT01271049Not applicable1 country
- Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, GhanaStatus unknownNCT01459146Phase 41 country
- Relative Efficacy of Two Regimens of Ante-helminthic TreatmentCompletedNCT00367627Not applicable1 country
- Management of Soil-transmitted Helminthiasis and StrongyloidiasisStatus unknownNCT01308268Not applicable1 country
- Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable1 country
- Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous LeishmaniasisCompletedNCT00469495Not applicable1 country
- Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control ProgrammesCompletedNCT004635931 country
- Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune ActivationCompletedNCT00130910Not applicable1 country
- Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in ZambiaCompletedNCT00276224Not applicable1 country